Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer

Prostate

Volumn 73, Issue 13, 2013, Pages 1441-1452

  Zenzmaier, Christoph ^a,b   Sampson, Natalie ^a,c   Plas, Eugen ^d   Berger, Peter ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d HANUSCH HOSPITAL   (Austria)

Author keywords

angiogenic factors; angiopoietin; myofibroblast differentiation; proliferation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOGENIC FACTOR; BETA CATENIN; DICKKOPF RELATED PROTEIN 3; GLYCOPROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA; SMOOTH MUSCLE ACTIN; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STROMA CELL;

ANGIOGENIC FACTORS; ANGIOPOIETIN; MYOFIBROBLAST DIFFERENTIATION; PROLIFERATION;

ANGIOPOIETIN-1; ANIMALS; BETA CATENIN; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; PHOSPHORYLATION; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 84882241681     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22691     Document Type: Article

References (48)

1. Zenzmaier C, Untergasser G, Hermann M, Dirnhofer S, Sampson N, Berger P,. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue. Prostate 2008; 68 (5): 540-547.
2. Zenzmaier C, Heitz M, Klocker H, Buck M, Gardiner RA, Berger P,. Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients. J Transl Med 2011; 9: 193.
3. Hsieh SY, Hsieh PS, Chiu CT, Chen WY,. Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene 2004; 23 (57): 9183-9189.
4. Kawano Y, Kitaoka M, Hamada Y, Walker MM, Waxman J, Kypta RM,. Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene 2006; 25 (49): 6528-6537.
5. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, Brown DE, Guyot D, Mays G, Leiby K, Chang B, Duong T, Goodearl AD, Gearing DP, Sokol SY, McCarthy SA,. Functional and structural diversity of the human Dickkopf gene family. Gene 1999; 238 (2): 301-313.
6. Niehrs C,. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006; 25 (57): 7469-7481.
7. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, Delius H, Hoppe D, Stannek P, Walter C, Glinka A, Niehrs C,. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 2002; 417 (6889): 664-667.
8. Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C,. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 2001; 411 (6835): 321-325.
9. Hoang BH, Kubo T, Healey JH, Yang R, Nathan SS, Kolb EA, Mazza B, Meyers PA, Gorlick R,. Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res 2004; 64 (8): 2734-2739.
10. Yue W, Sun Q, Dacic S, Landreneau RJ, Siegfried JM, Yu J, Zhang L,. Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Carcinogenesis 2008; 29 (1): 84-92.
11. Nakamura RE, Hunter DD, Yi H, Brunken WJ, Hackam AS,. Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retina. BMC Cell Biol 2007; 8: 52.
12. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y, Namba M,. A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 2000; 268 (1): 20-24.
13. Tsuji T, Nozaki I, Miyazaki M, Sakaguchi M, Pu H, Hamazaki Y, Iijima O, Namba M,. Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. Biochem Biophys Res Commun 2001; 289 (1): 257-263.
14. Nozaki I, Tsuji T, Iijima O, Ohmura Y, Andou A, Miyazaki M, Shimizu N, Namba M,. Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer. Int J Oncol 2001; 19 (1): 117-121.
15. Kurose K, Sakaguchi M, Nasu Y, Ebara S, Kaku H, Kariyama R, Arao Y, Miyazaki M, Tsushima T, Namba M, Kumon H, Huh NH,. Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol 2004; 171 (3): 1314-1318.
16. Kobayashi K, Ouchida M, Tsuji T, Hanafusa H, Miyazaki M, Namba M, Shimizu N, Shimizu K,. Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells. Gene 2002; 282 (1-2): 151-158.
17. Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H,. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 2005; 65 (10): 4218-4227.
18. Sakaguchi M, Kataoka K, Abarzua F, Tanimoto R, Watanabe M, Murata H, Than SS, Kurose K, Kashiwakura Y, Ochiai K, Nasu Y, Kumon H, Huh NH,. Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. J Biol Chem 2009; 284 (21): 14236-14244.
19. Tanimoto R, Sakaguchi M, Abarzua F, Kataoka K, Kurose K, Murata H, Nasu Y, Kumon H, Huh NH,. Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3. Int J Cancer 2010; 126 (7): 1562-1569.
20. Kobayashi T, Sakaguchi M, Tanimoto R, Abarzua F, Takaishi M, Kaku H, Kataoka K, Saika T, Nasu Y, Miyazaki M, Kumon H, Huh NH,. Mechanistic analysis of resistance to REIC/Dkk-3-induced apoptosis in human bladder cancer cells. Acta Med Okayama 2008; 62 (6): 393-401.
21. Zenzmaier C, Hermann M, Hengster P, Berger P,. Dickkopf-3 maintains the PANC-1 human pancreatic tumor cells in a dedifferentiated state. Int J Oncol 2012; 40 (1): 40-46.
22. Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW,. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 2007; 67 (9): 4244-4253.
23. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR,. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 2005; 65 (19): 8887-8895.
24. Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR,. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res 2002; 62 (21): 6021-6025.
25. Verona EV, Elkahloun AG, Yang J, Bandyopadhyay A, Yeh IT, Sun LZ,. Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling. Cancer Res 2007; 67 (12): 5737-5746.
26. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR,. Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002; 8 (9): 2912-2923.
27. Untergasser G, Gander R, Lilg C, Lepperdinger G, Plas E, Berger P,. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation. Mech Ageing Dev 2005; 126 (1): 59-69.
28. Zenzmaier C, Sampson N, Pernkopf D, Plas E, Untergasser G, Berger P,. Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasia. Endocrinology 2010; 151 (8): 3975-3984.
29. Sampson N, Koziel R, Zenzmaier C, Bubendorf L, Plas E, Jansen-Durr P, Berger P,. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Mol Endocrinol 2011; 25 (3): 503-515.
30. Zenzmaier C, Kern J, Sampson N, Heitz M, Plas E, Untergasser G, Berger P,. Phosphodiesterase type 5 inhibition reverts prostate fibroblast-to- myofibroblast trans-differentiation. Endocrinology 2012; 153 (11): 5546-5555.
31. Bergers G, Benjamin LE,. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3 (6): 401-410.
32. Tait CR, Jones PF,. Angiopoietins in tumours: The angiogenic switch. J Pathol 2004; 204 (1): 1-10.
33. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW,. Genes expressed in human tumor endothelium. Science 2000; 289 (5482): 1197-1202.
34. Untergasser G, Steurer M, Zimmermann M, Hermann M, Kern J, Amberger A, Gastl G, Gunsilius E,. The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation. Int J Cancer 2008; 122 (7): 1539-1547.
35. Fong D, Hermann M, Untergasser G, Pirkebner D, Draxl A, Heitz M, Moser P, Margreiter R, Hengster P, Amberger A,. Dkk-3 expression in the tumor endothelium: A novel prognostic marker of pancreatic adenocarcinomas. Cancer Sci 2009; 100 (8): 1414-1420.
36. Li Y, Ye X, Tan C, Hongo JA, Zha J, Liu J, Kallop D, Ludlam MJ, Pei L,. Axl as a potential therapeutic target in cancer: Role of Axl in tumor growth, metastasis and angiogenesis. Oncogene 2009; 28 (39): 3442-3455.
37. Zenzmaier C, Marksteiner J, Kiefer A, Berger P, Humpel C,. Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients. J Neurochem 2009; 110 (2): 653-661.
38. Zenzmaier C, Sklepos L, Berger P,. Increase of Dkk-3 blood plasma levels in the elderly. Exp Gerontol 2008; 43 (9): 867-870.
39. Jung IL, Kang HJ, Kim KC, Kim IG,. Knockdown of the Dickkopf 3 gene induces apoptosis in a lung adenocarcinoma. Int J Mol Med 2010; 26 (1): 33-38.
40. Lin PY, Fosmire SP, Park SH, Park JY, Baksh S, Modiano JF, Weiss RH,. Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: A potential mechanism of apoptosis resistance. Mol Cancer 2007; 6: 16.
41. Rossig L, Badorff C, Holzmann Y, Zeiher AM, Dimmeler S,. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J Biol Chem 2002; 277 (12): 9684-9689.
42. Romero D, Kawano Y, Bengoa N, Walker MM, Maltry N, Niehrs C, Waxman J, Kypta R,. Downregulation of Dickkopf-3 disrupts prostate acinar morphogenesis through TGF-beta/Smad signaling. J Cell Sci 2013; 126 (8): 1858-1867.
43. Berry SJ, Isaacs JT,. Comparative aspects of prostatic growth and androgen metabolism with aging in the dog versus the rat. Endocrinology 1984; 114 (2): 511-520.
44. Isaacs JT,. Antagonistic effect of androgen on prostatic cell death. Prostate 1984; 5 (5): 545-557.
45. Meyer JS, Sufrin G, Martin SA,. Proliferative activity of benign human prostate, prostatic adenocarcinoma and seminal vesicle evaluated by thymidine labeling. J Urol 1982; 128 (6): 1353-1356.
46. Pinho S, Niehrs C,. Dkk3 is required for TGF-beta signaling during Xenopus mesoderm induction. Differentiation; research in biological diversity 2007; 75 (10): 957-967.
47. Tsigkos S, Zhou Z, Kotanidou A, Fulton D, Zakynthinos S, Roussos C, Papapetropoulos A,. Regulation of Ang2 release by PTEN/PI3-kinase/Akt in lung microvascular endothelial cells. J Cell Physiol 2006; 207 (2): 506-511.
48. Jiang BH, Liu LZ,. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 2009; 102: 19-65.